These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 1978872)
1. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Wong CS; Pavord ID; Williams J; Britton JR; Tattersfield AE Lancet; 1990 Dec; 336(8728):1396-9. PubMed ID: 1978872 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists. Burgess CD; Flatt A; Siebers R; Crane J; Beasley R; Purdie G Eur J Clin Pharmacol; 1989; 36(4):415-7. PubMed ID: 2567672 [TBL] [Abstract][Full Text] [Related]
3. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline. Deenstra M; Haalboom JR; Struyvenberg A Eur J Clin Invest; 1988 Apr; 18(2):162-5. PubMed ID: 2898368 [TBL] [Abstract][Full Text] [Related]
4. Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Bremner P; Burgess C; Beasley R; Woodman K; Marshall S; Crane J; Pearce N Respir Med; 1992 Sep; 86(5):419-23. PubMed ID: 1462021 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma. Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398 [TBL] [Abstract][Full Text] [Related]
6. Studies on the bronchodilator, tremorogenic, cardiovascular and hypokalaemic effects of fenoterol dry powder in asthma. Bauer KG; Kaik B; Sertl K; Kaik GA Br J Clin Pharmacol; 1993 Oct; 36(4):285-92. PubMed ID: 12959305 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol. Scalabrin DM; Solé D; Naspitz CK J Asthma; 1996; 33(6):407-15. PubMed ID: 8968295 [TBL] [Abstract][Full Text] [Related]
8. The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma. Windom HH; Burgess CD; Siebers RW; Purdie G; Pearce N; Crane J; Beasley R Clin Pharmacol Ther; 1990 Sep; 48(3):296-301. PubMed ID: 1976051 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Crane J; Burgess C; Beasley R Thorax; 1989 Feb; 44(2):136-40. PubMed ID: 2928998 [TBL] [Abstract][Full Text] [Related]
10. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Scheinin M; Koulu M; Laurikainen E; Allonen H Br J Clin Pharmacol; 1987 Nov; 24(5):645-53. PubMed ID: 2829953 [TBL] [Abstract][Full Text] [Related]
11. [The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer]. Budmiger H; Kyd K; Scherrer M Schweiz Med Wochenschr; 1978 Aug; 108(31):1190-7. PubMed ID: 675213 [TBL] [Abstract][Full Text] [Related]
12. A cumulative dose comparison between salbutamol and fenoterol metered dose aerosols in asthmatic patients. Bellamy D; Penketh A Postgrad Med J; 1987 Jun; 63(740):459-61. PubMed ID: 3432172 [TBL] [Abstract][Full Text] [Related]
13. Dose-effect relationship of the beta-agonists fenoterol and salbutamol in patients with asthma. Newhouse MT; Dolovich MB; Kazim F Chest; 1994 Jun; 105(6):1738-42. PubMed ID: 8205869 [TBL] [Abstract][Full Text] [Related]
14. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study. Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051 [TBL] [Abstract][Full Text] [Related]
15. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease. Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625 [TBL] [Abstract][Full Text] [Related]
16. Effects of airway calibre on lung delivery of nebulised salbutamol. Lipworth BJ; Clark DJ Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895 [TBL] [Abstract][Full Text] [Related]
17. A dose response study comparing Duovent vs salbutamol. Stewart DE; Gillies AJ N Z Med J; 1987 Dec; 100(837):742-4. PubMed ID: 2967936 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of inhaled dry powder formulations of fenoterol and colforsin in asthma. Bauer K; Dietersdorfer F; Sertl K; Kaik B; Kaik G Clin Pharmacol Ther; 1993 Jan; 53(1):76-83. PubMed ID: 8422745 [TBL] [Abstract][Full Text] [Related]
19. Carbuterol, fenoterol, orciprenaline, salbutamol and terbutaline per os in reversible obstructive chronic bronchitis. Minette A; Marcq M; Gepts L Bull Eur Physiopathol Respir; 1976; 12(4):545-53. PubMed ID: 13895 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients. Lipworth BJ; Newnham DM; Clark RA; Dhillon DP; Winter JH; McDevitt DG Thorax; 1995 Jan; 50(1):54-61. PubMed ID: 7886650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]